Abstract:Objective To investigate the prevalence of atherosclerosis and analyze the risk factors in patients with end stage renal disease(ESRD) Methods 100 ESRD patients were divided into three groups as non-dialysis ( n = 28), hemodialysis ( n = 31) and continuous ambulatory peritoneal dialysis (CAPD) ( n=41). Duration of dialysis ranged from 1 to 5 years. Their carotid atherosclerosis was evaluated and hemodynamic parameters, including velocity (systolic and diastolic) and resistance index ( RI) of common carotid artery were measured by B-ultrasound. Simultaneously their medical history and biochemical parameters were collected. Results 31 % of all patients presented carotid atherosclerosis, and no difference of the incidence among these three groups was found. Stepwise regression analysis showed that history of ischemic cerebrocardiovascular accidence( R~2=0. 3054, P=0. 0001), fibrinogen( R~2=0. 3750. P = 0. 0037) and RI( R~2=0. 4062, P= 0. 0270) were associated with the maximum IMT, and history of ischemic cerebrocardiovascular accidence( R~2 = 0. 2606, P = 0. 0001) , DV( R~2 = 0.4375, P = 0. 0177) ,age (R~2 = 0. 3657, P=0. 0001), cigarette smoking( R~2 = 0. 4030, P=0. 0161) were associated with the mean IMT. Logistic regression analysis identified three independent risk factors, namely history of ischemic cerebrocardiovascular accidence. cigarette smoking and RI. Gender, albumin, cholesterol, triglyceride. HDL, LDL, apoA/apoB100 and duration of dialysis were not significantly associated with carotid atherosclerosis. Conclusions The prevalence of carotid atherosclerosis is high, reaching 31% in ESRD patients. Risk factors correlated with carotid atherosclerosis in ESRD patients are age, smoking, hypertension. hyperfibrinogen, high resistance index (RI) . And history of ischemic cerebrocardiovasculer disease can indicate potential atherosclerosis. ESRD per se may be atherosclerogenesis and dialysis is not found to aggravate atherosclerosis in 1 to 5 years. Furthermore B-ultrasound of carotid artery as a non-invasion method is helpful for the identification of cardiovascular atherosclerosis and its follow-up in ESRD patients, meanwhile it can be used to measure hemodynamic parameters.

Level of Asymmetric Dimethylarginine and Carotid Atherosclerosis in Patients with Chronic Kidney Disease.

Relations Between Plasma Asymmetric Dimethylarginine (adma) and Risk Factors for Coronary Disease

Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of l-arginine on its metabolism

Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.

Asymmetric Dimethylarginine: A Novel Risk Factor for Cardiovascular Disease

Arginine Metabolites as Biomarkers of Myocardial Ischaemia, Assessed with Cardiac Magnetic Resonance Imaging in Chronic Kidney Disease

The Role Of ADMA in Cardiovascular Complication of Patients in Chronic Kidney Disease

Asymmetric dimethylarginine serum concentration in normal weight and obese CKD patients treated with hemodialysis

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients

Asymmetric Dimethylarginine as a Biomarker in Coronary Artery Disease

Dialysis Methods May Affect Carotid Intima–Media Thickness in Chinese End-Stage Renal Disease Patients

Asymmetric Dimethylarginine in Homocystinuria Due to Cystathionine Β-Synthase Deficiency: Relevance of Renal Function

Aortic Root Dilatation is Associated with Carotid Intima-Media Thickness but Not with Carotid Plaque in Hypertensive Men

Relations Between Markers of Renal Function, Coronary Risk Factors and the Occurrence and Severity of Coronary Artery Disease

Asymmetric and Symmetric Dimethylarginines Are of Similar Predictive Value for Cardiovascular Risk in the General Population.

Increased Levels of Asymmetric Dimethylarginine and C-reactive Protein Are Associated with Impaired Vascular Reactivity in Essential Hypertension.

Relationship Between Soluble Receptor of Advanced Glycation End Product and Carotid Atherosclerosis in Patients under Hemodialysis

Asymmetric dimethylarginine (ADMA) is associated with reduced myocardial mechano-energetic efficiency in hypertensive subjects

Investigation of the Prevalence of Atherosclerosis and Analysis of Its Risk Factors in Patients with End Stage Renal Disease

Asymmetric Dimethyarginine As Marker And Mediator In Ischemic Stroke

High Plasma Dimethylarginine Levels Are Associated with Adverse Clinical Outcome after Stroke.